BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31698791)

  • 21. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
    Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
    Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
    Singh A; Gupta S; Badarukhiya JA; Sachan M
    Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications.
    Barros-Silva D; Marques CJ; Henrique R; Jerónimo C
    Genes (Basel); 2018 Aug; 9(9):. PubMed ID: 30142958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer.
    Birknerova N; Mancikova V; Paul ED; Matyasovsky J; Cekan P; Palicka V; Parova H
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
    Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
    Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
    Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
    Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using circulating cell-free DNA to monitor personalized cancer therapy.
    Oellerich M; Schütz E; Beck J; Kanzow P; Plowman PN; Weiss GJ; Walson PD
    Crit Rev Clin Lab Sci; 2017 May; 54(3):205-218. PubMed ID: 28393575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-Free DNA Fragmentomics in Liquid Biopsy.
    Ding SC; Lo YMD
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients.
    Boldrin E; Curtarello M; Dallan M; Alfieri R; Realdon S; Fassan M; Saggioro D
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary Nucleic Acid in Tumor: Bioinformatics Approaches.
    Angeli D
    Methods Mol Biol; 2021; 2292():95-104. PubMed ID: 33651354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications.
    Sacdalan DB; Ul Haq S; Lok BH
    Curr Oncol; 2024 Jan; 31(1):482-500. PubMed ID: 38248118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of genome-wide in cell free DNA methylation: progress and prospect.
    Liu Z; Wang Z; Jia E; Ouyang T; Pan M; Lu J; Ge Q; Bai Y
    Analyst; 2019 Oct; 144(20):5912-5922. PubMed ID: 31436778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer.
    Liu X; Liu L; Ji Y; Li C; Wei T; Yang X; Zhang Y; Cai X; Gao Y; Xu W; Rao S; Jin D; Lou W; Qiu Z; Wang X
    EBioMedicine; 2019 Mar; 41():345-356. PubMed ID: 30857943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker.
    Martins-Ferreira R; Leal BG; Costa PP
    Front Cell Neurosci; 2022; 16():852151. PubMed ID: 35401115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures.
    Oberhofer A; Bronkhorst AJ; Uhlig C; Ungerer V; Holdenrieder S
    Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 36010184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNA.
    Sigalotti L; Covre A; Colizzi F; Fratta E
    Methods Mol Biol; 2019; 1909():137-162. PubMed ID: 30580429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Free DNA and Its Emerging Role in Autoimmune Diseases.
    Mondelo-Macía P; Castro-Santos P; Castillo-García A; Muinelo-Romay L; Diaz-Peña R
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
    Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
    Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.